Table 3 Mean scores during follow-up
|  | Follow-up cohort at 3 months | Follow-up cohort at 6 months | Follow-up cohort at 12 months | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
N | Mean scores (SD) | 95% CI | N | Mean scores (SD) | 95% CI | p value (∆3 to 6 months) | N | Mean scores (SD) | 95% CI | p value (∆3 to 12 months) | |
CFQ | 40 | 29.7 (13.7) | 25.4–33.9 | 47 | 30.3 (14.6) | 26.2–34.5 | 0.62 | 41 | 31.6 (13.9) | 27.3–35.8 | 0.18 |
HADS—anxiety | 57 | 4.2 (4.1) | 3.2–5.3 | 51 | 3.8 (3.9) | 2.7–4.9 | 0.22 | 41 | 3.7 (3.6) | 2.6–4.8 | 0.12 |
HADS—depression | 57 | 4.7 (4.1) | 3.7–5.8 | 51 | 4.3 (4.0) | 3.3–5.4 | 0.32 | 41 | 4.5 (3.7) | 3.4–5.7 | 0.65 |
PTSS-10 | 57 | 21.2 (11.0) | 18.3–24.0 | 51 | 22.0 (10.6) | 19.1–24.9 | 0.35 | 41 | 21.3 (9.8) | 18.3–24.3 | 0.91 |
CANTAB | |||||||||||
 PRM—% correct | 58 | 82.8 (10.4) | 80.1–85.5 | 51 | 85.9 (10.3) | 83.8–88.7 | 0.03 | 45 | 85.2 (10.1) | 82.2–88.1 | 0.12 |
 RVP—RVP A’ | 57 | 0.87 (0.06) | 0.85–0.88 | 47 | 0.89 (0.06) | 0.87–0.91 | 0.01 | 41 | 0.90 (0.06) | 0.88–0.92 | < 0.001 |
 SOC—minimum moves | 57 | 8.4 (1.9) | 7.9–8.9 | 49 | 8.8 (1.9) | 8.3–9.3 | 0.19 | 45 | 9.4 (1.9) | 8.9–10.0 | < 0.001 |
 SSP—span length | 58 | 5.8 (1.3) | 5.5–6.2 | 51 | 5.9 (1.3) | 5.6–6.3 | 0.60 | 45 | 5.9 (1.3) | 5.6–6.3 | 0.61 |